Chimeric antigen receptor T cell therapy based on stem cell-like memory T cells enhances anti-tumour effects in multiple myeloma

Zhaoyun Liu; Xintong Xu; Yihao Wang; Panpan Cao; Jia Song; Kai Ding; Hui Liu; Rong Fu

doi:10.1002/ctm2.70264

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (3) : e70264 DOI: 10.1002/ctm2.70264

LETTER TO THE JOURNAL

Chimeric antigen receptor T cell therapy based on stem cell-like memory T cells enhances anti-tumour effects in multiple myeloma

Zhaoyun Liu ¹^,²^,³^,⁴^,⁵
, Xintong Xu ¹^,²^,³^,⁴^,⁵
, Yihao Wang ¹^,²^,³^,⁴^,⁵
, Panpan Cao ¹^,²^,³^,⁴^,⁵
, Jia Song ¹^,²^,³^,⁴^,⁵
, Kai Ding ¹^,²^,³^,⁴^,⁵
, Hui Liu ¹^,²^,³^,⁴^,⁵
, Rong Fu ¹^,²^,³^,⁴^,⁵^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Zhaoyun Liu, Xintong Xu, Yihao Wang, Panpan Cao, Jia Song, Kai Ding, Hui Liu, Rong Fu. Chimeric antigen receptor T cell therapy based on stem cell-like memory T cells enhances anti-tumour effects in multiple myeloma. Clinical and Translational Medicine, 2025, 15(3): e70264 DOI:10.1002/ctm2.70264

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Minnie SA, Hill GR. Immunotherapy of multiple myeloma. J Clin Invest. 2020;130(4):1565-1575.

[2]	Rasche L, Hudecek M, Einsele H. CAR T-cell therapy in multiple myeloma: mission accomplished? Blood. 2024;143(4):305-310.

[3]	Parikh RH, Lonial S. Chimeric antigen receptor T-cell therapy in multiple myeloma: a comprehensive review of current data and implications for clinical practice. CA Cancer J Clin. 2023;73(3):275-285.

[4]	Biasco L, Scala S, Basso Ricci L, et al. In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells. Sci Transl Med. 2015;7(273):273ra13.

[5]	Biasco L, Izotova N, Rivat C, et al. Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients. Nat Cancer. 2021;2(6):629-642.

[6]	Lu Y, Wang Q, Xue G, et al. Th9 Cells Represent a Unique Subset of CD4(+) T Cells Endowed with the Ability to Eradicate Advanced Tumors. Cancer Cell. 2018;33(6):1048-1060.e7.

[7]	Wang Y, Qiu F, Xu Y, et al. Stem cell-like memory T cells: the generation and application. J Leukoc Biol. 2021;110(6):1209-1223.

[8]	Wang X, Tao X, Chen P, et al. MEK inhibition prevents CAR-T cell exhaustion and differentiation via downregulation of c-Fos and JunB. Signal Transduct Target Ther. 2024;9(1):293.

[9]	Verma V, Jafarzadeh N, Boi S, et al. MEK inhibition reprograms CD8(+) T lymphocytes into memory stem cells with potent antitumor effects. Nat Immunol. 2021;22(1):53-66.

[10]	Porcellini S, Asperti C, Corna S, et al. CAR T cells redirected to CD44v6 control tumor growth in lung and ovary adenocarcinoma bearing mice. Front Immunol. 2020;11:99.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.